Hermus A R, Pieters G F, Pesman G J, Hofman J, Smals A G, Benraad T J, Kloppenborg P W
Clin Endocrinol (Oxf). 1987 Jan;26(1):67-74. doi: 10.1111/j.1365-2265.1987.tb03640.x.
The response of ACTH and cortisol to corticotrophin-releasing hormone (CRH) after pretreatment with various doses of dexamethasone was investigated in five healthy subjects. The five subjects participated in six experiments. In each experiment 200 micrograms ovine CRH was administered as an i.v. bolus injection at 0900 h after pretreatment with respectively: (A) 1 mg dexamethasone orally at 2300 h in the evening before CRH injection, (B) 2 mg dexamethasone orally at 2300 h in the evening before CRH injection, (C) 4 mg dexamethasone orally at 2300 h in the evening before CRH injection, (D) 2 mg dexamethasone orally at 2300 h in the evening before CRH injection, followed by 2 mg dexamethasone orally 1 h before CRH, (E) no dexamethasone and (F) 1 mg dexamethasone orally 1 h before CRH injection. In spite of overnight suppression with a single dose of dexamethasone CRH elicited cortisol rises in all individuals (experiments A-C). Dexamethasone pretreatment in experiment D abolished the CRH-induced stimulation of the pituitary-adrenal axis. There was a significant and negative correlation between the basal dexamethasone levels (i.e. the dexamethasone levels immediately before CRH administration) in the experiments A-D and the areas under the individual ACTH (R = -0.62; P less than 0.01 by Spearman's rank correlation test) and cortisol (R = -0.81; P less than 0.001 by Spearman's test) curves, i.e. the lower the basal dexamethasone levels, the greater the rise in ACTH and cortisol levels after CRH administration.(ABSTRACT TRUNCATED AT 250 WORDS)
在五名健康受试者中研究了用不同剂量地塞米松预处理后促肾上腺皮质激素(ACTH)和皮质醇对促肾上腺皮质激素释放激素(CRH)的反应。这五名受试者参与了六项实验。在每项实验中,于上午9点静脉推注200微克羊CRH,分别在以下预处理后进行:(A)在CRH注射前一晚23点口服1毫克地塞米松;(B)在CRH注射前一晚23点口服2毫克地塞米松;(C)在CRH注射前一晚23点口服4毫克地塞米松;(D)在CRH注射前一晚23点口服2毫克地塞米松,然后在CRH注射前1小时口服2毫克地塞米松;(E)不使用地塞米松;(F)在CRH注射前1小时口服1毫克地塞米松。尽管单剂量地塞米松进行了过夜抑制,但CRH仍使所有个体的皮质醇升高(实验A - C)。实验D中的地塞米松预处理消除了CRH诱导的垂体 - 肾上腺轴刺激。在实验A - D中,基础地塞米松水平(即紧接CRH给药前的地塞米松水平)与个体ACTH曲线下面积(Spearman等级相关检验,R = -0.62;P < 0.01)和皮质醇曲线下面积(Spearman检验,R = -0.81;P < 0.001)之间存在显著的负相关,即基础地塞米松水平越低,CRH给药后ACTH和皮质醇水平的升高幅度越大。(摘要截断于250字)